Anke Vennegoor

Research output

Research output per year 2009 2010 2011 2014 2015 2016 2017 2023

• 30 Article
• 1 Phd-Thesis - Research and graduation internal

Research output per year

Research output per year

Search results

• 2023

  Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)

  Toorop, A. A., van Lierop, Z. Y., Gelissen, L. M., Hoitsma, E., Zeinstra, E. M., van Rooij, L. C., van Munster, C. E., Vennegoor, A., Mostert, J. P., Wokke, B. H., Kalkers, N. F., Hoogervorst, E. L., van Eijk, J. J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J., Sinnige, L., Kloosterziel, M. E., & 16 othersArnoldus, E. P., van Dijk, G. W., Bouvy, W. H., Wessels, M. H., Boonkamp, L., Strijbis, E. M., van Oosten, B. W., De Jong, B. A., Lissenberg-Witte, B. I., Barkhof, F., Moraal, B., Teunissen, C. E., Rispens, T., Uitdehaag, B. M., Killestein, J. & van Kempen, Z. LE., 14 Nov 2023, (E-pub ahead of print) In: Journal of neurology, neurosurgery, and psychiatry.

  Research output: Contribution to journal › Article › Academic
  2 Citations (Scopus)
• 2019

  High work absence around time of diagnosis of multiple sclerosis is associated with fatigue and relapse rate

  Doesburg, D., Vennegoor, A., Uitdehaag, B. M. J. & van Oosten, B. W., 1 Jun 2019, In: Multiple Sclerosis and Related Disorders. 31, p. 32-37 6 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  7 Citations (Scopus)
• 2018

  The fat embolism syndrome as a cause of paraplegia

  Peters, S. T., Witvliet, M. J., Vennegoor, A., Ten Tusscher, B., Boden, B. & Bloemers, F. W., 2018, In: SAGE open medical case reports. 6, p. 2050313X18789318

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
• 2017

  John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients

  van Kempen, Z. L. E., Leurs, C. E., de Vries, A., Vennegoor, A., Rispens, T., Wattjes, M. P. & Killestein, J., 1 Sept 2017, In: European journal of neurology. 24, 9, p. 1196-1199 4 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  9 Citations (Scopus)

• Natalizumab: The road towards personalized medicine

  Vennegoor, A., 2017, 119 p.

  Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

  Open Access

• Natalizumab-associated progressive multifocal leukoencephalopathy is not preceded by elevated drug concentrations

  van Kempen, Z. LE., Leurs, C. E., Vennegoor, A., Wattjes, M. P., Rispens, T., Uitdehaag, B. M. & Killestein, J., 1 Jun 2017, In: MULTIPLE SCLEROSIS. 23, 7, p. 995-999 5 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  5 Citations (Scopus)

• Neutralizing capacity of monoclonal and polyclonal anti-natalizumab antibodies: The immune response to antibody therapeutics preferentially targets the antigen-binding site

  van Schie, K. A., Kruithof, S., van Schouwenburg, P. A., Vennegoor, A., Killestein, J., Wolbink, G. & Rispens, T., 1 Mar 2017, In: Journal of allergy and clinical immunology. 139, 3, p. 1035-1037.e6

  Research output: Contribution to journal › Article › Academic › peer-review
  20 Citations (Scopus)
• 2016

  Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients

  Wattjes, M. P., Wijburg, M. T., Vennegoor, A., Witte, B. I., Roosendaal, S. D., Sanchez, E., Liu, Y., Martins Jarnalo, C. O., Richert, N. D., Uitdehaag, B. M. J., Barkhof, F. & Killestein, J., Aug 2016, In: Multiple sclerosis (Houndmills, Basingstoke, England). 22, 9, p. 1174-1183

  Research output: Contribution to journal › Article › Academic › peer-review
  21 Citations (Scopus)

• High cumulative JC virus seroconversion rate during long-term use of natalizumab

  Vennegoor, A., van Rossum, J. A., Leurs, C., Wattjes, M. P., Rispens, T., Murk, J. L. A. N., Uitdehaag, B. M. J. & Killestein, J., Jun 2016, In: European journal of neurology. 23, 6, p. 1079-1085

  Research output: Contribution to journal › Article › Academic › peer-review
  43 Citations (Scopus)

• MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS

  Wattjes, M. P., Wijburg, M. T., Vennegoor, A., Witte, B. I., de Vos, M., Richert, N. D., Uitdehaag, B. M. J., Barkhof, F., Killestein, J. & van Oosten, BW., Aug 2016, In: Journal of Neurology, Neurosurgery and Psychiatry. 87, 8, p. 879-884

  Research output: Contribution to journal › Article › Academic › peer-review
  41 Citations (Scopus)

• MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance

  Wijburg, M. T., Witte, B. I., Vennegoor, A., Roosendaal, S. D., Sanchez, E., Liu, Y., Martins Jarnalo, C. O., Uitdehaag, B. M. J., Barkhof, F., Killestein, J. & Wattjes, M. P., Oct 2016, In: Journal of neurology, neurosurgery, and psychiatry. 87, 10, p. 1138-1145

  Research output: Contribution to journal › Article › Academic › peer-review
  52 Citations (Scopus)
• 2015

  Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy

  Vennegoor, A., Rispens, T., van Oosten, B. W., Wattjes, M. P., Wondergem, M. J., Teunissen, C. E., van der Kleij, D., Uitdehaag, B. M. J., Polman, C. H. & Killestein, J., 2015, In: MULTIPLE SCLEROSIS. 21, 4, p. 481-484

  Research output: Contribution to journal › Article › Academic › peer-review
  13 Citations (Scopus)

• Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy

  Vennegoor, A., van Rossum, J. A., Polman, C. H., Wattjes, M. P. & Killestein, J., 2015, In: MULTIPLE SCLEROSIS. 21, 12, p. 1600-1603

  Research output: Contribution to journal › Article › Academic › peer-review
  22 Citations (Scopus)

• MRI pattern in asymptomatic natalizumab-associated PML

  Wattjes, M. P., Vennegoor, A., Steenwijk, M. D., Vos, M., Killestein, J., van Oosten, B. W., Mostert, J., Siepman, D. A., Moll, W., van Golde, A. E. L., Frequin, S. T. F. M., Richert, N. D. & Barkhof, F., 2015, In: Journal of Neurology, Neurosurgery and Psychiatry. 86, 7, p. 793-798

  Research output: Contribution to journal › Article › Academic › peer-review
  63 Citations (Scopus)
• 2014

  Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?

  Wattjes, M. P., Vennegoor, A., Mostert, J., van Oosten, B. W., Barkhof, F. & Killestein, J., 2014, In: Journal of neurology. 261, 6, p. 1139-1143

  Research output: Contribution to journal › Article › Academic › peer-review
  27 Citations (Scopus)

• PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation

  Killestein, J., Vennegoor, A., van Golde, A. E., Bourez, R. L., Wijlens, M. L. & Wattjes, M. P., 2014, In: Case reports in neurological medicine. 2014, p. 307872 307872.

  Research output: Contribution to journal › Article › Academic › peer-review

• Safety, anxiety and natalizumab continuation in JC virus-seropositive MS patients

  van Rossum, J. A., Vennegoor, A., Balk, L., Uitdehaag, B. M. J., Polman, C. H. & Killestein, J., 2014, In: MULTIPLE SCLEROSIS. 20, 1, p. 108-111

  Research output: Contribution to journal › Article › Academic › peer-review
  8 Citations (Scopus)

• The effect of prolonged natalizumab treatment on anxiety and safety in JC virus-seropositive MS patients; a follow-up study

  van Rossum, J. A., Vennegoor, A. & Killestein, J., 2014, In: MULTIPLE SCLEROSIS. 20, 12, p. 1668-1669

  Research output: Contribution to journal › Article › Academic › peer-review
  1 Citation (Scopus)

• The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA

  Simmelink, M. J. A., Vennegoor, A., Killestein, J., Blankenstein, M. A., Norgren, N., Korth, C. & Teunissen, C. E., 2014, In: Journal of immunological methods. 402, 1-2, p. 43-49

  Research output: Contribution to journal › Article › Academic › peer-review
  55 Citations (Scopus)
• 2013

  Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis

  Vennegoor, A., Rispens, T., Strijbis, E. M. M., Seewann, A., Uitdehaag, B. M. J., Balk, L. J., Barkhof, F., Polman, C. H., Wolbink, G. & Killestein, J., 2013, In: MULTIPLE SCLEROSIS. 19, 5, p. 593-600

  Research output: Contribution to journal › Article › Academic › peer-review
  106 Citations (Scopus)

• Drug interference in immunogenicity assays depends on valency

  Rispens, T., Hart, M. H., Ooijevaar-de Heer, P., van Leeuwen, A., Vennegoor, A., Killestein, J., Wolbink, G-J. & van der Kleij, D., 2013, In: Journal of Pharmaceutical and Biomedical Analysis. 85, p. 179-185

  Research output: Contribution to journal › Article › Academic › peer-review
  19 Citations (Scopus)
• 2012

  Natalizumab remains detectable in patients with multiple sclerosis long after treatment is stopped

  Rispens, T., Vennegoor, A., Wolbink, G. J., Polman, C. H. & Killestein, J., 2012, In: MULTIPLE SCLEROSIS JOURNAL. 18, 6, p. 899-901

  Research output: Contribution to journal › Article › Academic › peer-review
  37 Citations (Scopus)
• 2011

  Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients

  Ketelslegers, I. A., Modderman, P. W., Vennegoor, A., Killestein, J., Hamann, D. & Hintzen, R. Q., 2011, In: MULTIPLE SCLEROSIS. 17, 12, p. 1527-1530

  Research output: Contribution to journal › Article › Academic › peer-review
  40 Citations (Scopus)

• Indolent Course of Progressive Multifocal Leukoencephalopathy During Natalizumab Treatment in Ms

  Vennegoor, A., Wattjes, M. P., van Munster, E. T. L., Kriekaart, R. L., van Oosten, B. W., Barkhof, F., Killestein, J. & Polman, C. H., 2011, In: Neurology. 76, 6, p. 574-576

  Research output: Contribution to journal › Article › Academic › peer-review
  28 Citations (Scopus)

• Indolent Course of Progressive Multifocal Leukoencephalopathy During Natalizumab Treatment in Ms Reply

  Vennegoor, A., Wattjes, M., van Munster, E. T., Killestein, J. & Polman, C. H., 2011, In: Neurology. 77, 10, p. 1020-1020

  Research output: Contribution to journal › Article › Academic › peer-review

• Measurement of serum levels of natalizumab, an immunoglobulin G4 therapeutic monoclonal antibody

  Rispens, T., van Leeuwen, A., Vennegoor, A., Killestein, J., Aalberse, R. C., Wolbink, G. J. & Aarden, L. A., 2011, In: Analytical biochemistry. 411, 2, p. 271-276

  Research output: Contribution to journal › Article › Academic › peer-review
  60 Citations (Scopus)

• Reactie op ingezonden brief van drs. J.R. Schipper

  Strijbis, E. M. M. & Vennegoor, A., 2011, In: Tijdschrift voor neurologie & neurochirurgie. 112, 5, p. 200

  Research output: Contribution to journal › Article › Professional
• 2010

  Natalizumab Drug Holiday in Multiple Sclerosis: Poorly Tolerated

  Killestein, J., Vennegoor, A., Strijbis, E. M. M., Seewann, A. M., van Oosten, B. W., Uitdehaag, B. M. J. & Polman, C. H., 2010, In: Annals of neurology. 68, 3, p. 392-395

  Research output: Contribution to journal › Article › Academic › peer-review
  112 Citations (Scopus)

• Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS

  van der Voort, L. F., Vennegoor, A., Visser, A., Knol, D. L., Uitdehaag, B. M. J., Barkhof, F., Oudejans, C. B. M., Polman, C. H. & Killestein, J., 2010, In: Neurology. 75, 14, p. 1228-1233

  Research output: Contribution to journal › Article › Academic › peer-review
  31 Citations (Scopus)

• T lymphocytes impair P-glycoprotein function during neuroinflammation

  Kooij, G., van Horssen, J., de Lange, E. C. M., Reijerkerk, A., van der Pol, S. M. A., Hof, B. V., Drexhage, J. A. R., Vennegoor, A., Killestein, J., Scheffer, G. L., Oerlemans, R., Scheper, R. J., van der Valk, P., Dijkstra, C. D. & de Vries, H. E., 2010, In: Journal of autoimmunity. 34, 4, p. 416-425

  Research output: Contribution to journal › Article › Academic › peer-review
  61 Citations (Scopus)
• 2009

  MxA mRNA level predicts relapses in a prospective cohort of early MS patients

  van der Voort, L. F., Vennegoor, A., Visser, A., Knol, D. L., Uitdehaag, B. M. J., Barkhof, F., Oudejans, C. B. M., Polman, C. H. & Killestein, J., 2009, In: MULTIPLE SCLEROSIS. 15, 9, p. S271-S272

  Research output: Contribution to journal › Article › Academic › peer-review